News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Daily News CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices Michael O'Riordan October 30, 2020
News Conference News ESC 2020 Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib Todd Neale September 03, 2020
News Conference News ESC 2020 Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4 Shelley Wood August 29, 2020
News Daily News Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest Shelley Wood August 05, 2020
News Conference News HRS 2020 Micra Leadless Pacemaker Tied to Fewer Complications in Medicare Patients Todd Neale May 18, 2020
News Conference News ACC 2020 LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout Todd Neale April 06, 2020
News Conference News ACC 2020 Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS Todd Neale April 03, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020